富含IgG4阳性血细胞的慢性性食道炎 - 一个独特的临床病理实体
Hanna Henzinger1, Ian Brown2,3, Anthony J Gill4,5,6
1Diagnostic and Research Institute of Pathology, Diagnostic and Research Centre of Molecular BioMedicine, Medical University of Graz, Graz, Austria.
Histopathology
|March 9, 2026
概括
这项研究描述了慢性性食道炎的高IgG4阳性血细胞,发现它对皮质类固醇有反应. 这种情况与IgG4相关的疾病不同,对患者有很大的影响,但显示出有前途的治疗结果.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 慢性性食道炎可能对标准治疗不耐药.
- 一些病例呈现出密集的IgG4阳性血细胞透,但不符合IgG4相关疾病的全部标准.
研究的目的:
- 描述治疗不耐药的慢性性食道炎的临床和组织学特征,富含IgG4阳性血细胞.
- 为了评估这些患者的治疗反应.
主要方法:
- 在2019-2025年间诊断的12名患者的回顾性审查.
- 食道活检的组织学和免疫组织化学再评估.
- 发现与临床数据,症状和内镜信息的相关性.
主要成果:
- 12名患者 (平均年龄为63.1岁) 患有消化不良和胃烧.
- 4名患者血清IgG4升高;没有其他器官因IgG4相关疾病而受到影响.
- 内镜检查显示出病 (100%) 和收缩 (50%),主要发生在食道下部.
- 组织学显示了密集的IgG4阳性血细胞透 (平均70/HPF,73%的比率).
- 皮质类固醇改善了8/9名患者的症状,并在4/5.5实现了组织学缓解.
结论:
- 患有大量IgG4阳性血细胞的慢性性食道炎具有显著的临床影响.
- 这种情况似乎对皮质类固醇治疗有很好的反应.
- 对于诊断具有密集的血细胞透的治疗耐药食道来说,IgG4免疫组织化学是至关重要的.
相关概念视频
Gastritis-II: Pathophysiology
1.6K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.6K
Peptic Ulcer Disease I: Introduction
972
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
972
Chronic Bowel Disorders: Introduction
867
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
867
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
733
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
733
Barrett Esophagus-I: Introduction
1.1K
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.1K
Peptic Ulcer Disease IV: Management
601
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
601


